A Multicenter, Open-Label, Single Arm, Long-Term Extension Study of WA19926 to Describe Safety During Treatment With Tocilizumab in Patients With Early, Moderate to Severe Rheumatoid Arthritis
Phase of Trial: Phase III
Latest Information Update: 09 Feb 2018
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions; Registrational
- Sponsors Roche
- 07 Feb 2018 Status changed from completed to discontinued.
- 09 Mar 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 23 Feb 2015 Status changed from completed to active, no longer recruiting as per ClinicalTrials.gov record.